Marc Hoffmann
Overview
Explore the profile of Marc Hoffmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwiatek M, Guru Murthy G, Hoffmann M, Tessoulin B, Danilov A, Alencar A, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 40000354
Background: LOXO-338 is a novel, orally bioavailable small-molecule inhibitor of Bcl-2, designed to achieve selectivity for Bcl-2 over Bcl-xL, thus avoiding dose-limiting thrombocytopenia associated with Bcl-xL inhibition. This first-in-human, open-label,...
2.
Khan Q, Bohnenkamp C, Monson T, Phadnis M, Clark L, Smith H, et al.
JCO Oncol Adv
. 2025 Feb;
2(1):e2400068.
PMID: 39917581
Purpose: In metastatic breast cancer (MBC), oral capecitabine prescribed at the US Food and Drug Administration (FDA)-approved dose of 1,250 mg/m twice daily, 14 days on, 7 days off, is...
3.
Wang M, Jurczak W, Trneny M, Belada D, Wrobel T, Ghosh N, et al.
Lancet Oncol
. 2025 Feb;
26(2):200-213.
PMID: 39914418
Background: The combination of ibrutinib and venetoclax leverages complementary mechanisms of action and has shown promising clinical activity in mantle cell lymphoma (MCL). This study evaluated the efficacy and safety...
4.
Erler T, Droop F, Lubbert C, Knobloch J, Carlsen L, Papan C, et al.
Sci Total Environ
. 2024 Aug;
950:175344.
PMID: 39117207
The widespread dissemination of carbapenem-resistant bacteria in wastewater systems, particularly from clinical sources, poses a significant public health risk. This study assessed the concentrations and distributions of extracellular DNA (exDNA)...
5.
Lutfi F, Tun A, Hoffmann M, Ahmed N
Ann Palliat Med
. 2024 Apr;
13(3):729-732.
PMID: 38644555
No abstract available.
6.
Wesson W, Ahmed N, Rashid A, Tabak C, Logan E, Marchena-Burgos J, et al.
Eur J Haematol
. 2023 Dec;
112(4):538-546.
PMID: 38044594
Background: While chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment outcomes of relapsed/refractory hematological malignancies, this therapy is associated with post-treatment cytopenias, which can pose a challenge to...
7.
Wichmann C, Dengler J, Hoffmann M, Rosch P, Popp J
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Sep;
305:123425.
PMID: 37751647
Wastewater is a very complex and diverse medium, which despite low nutrient density still harbors bacteria. Especially the wastewater from hospitals contains a high germ load. However, wastewater is also...
8.
Hoffmann M, Gardein H, Greil H, Erler S
Parasitology
. 2023 May;
150(8):744-753.
PMID: 37157059
is an endoparasite of the mining bee with extreme sexual dimorphism and hypermetamorphosis. Its population structure, parasitization mode, genetic diversity and impact on host morphology were examined in nesting sites...
9.
Khan Q, Bivona C, Martin G, Zhang J, Liu B, He J, et al.
JAMA Oncol
. 2022 Apr;
8(7):1053-1058.
PMID: 35446353
Importance: The durability of the antibody response to COVID-19 vaccines in patients with cancer undergoing treatment or who received a stem cell transplant is unknown and may be associated with...
10.
Ahmed N, Shahzad M, Shippey E, Bansal R, Mushtaq M, Mahmoudjafari Z, et al.
Transplant Cell Ther
. 2022 Apr;
28(7):358-364.
PMID: 35429662
Chimeric antigen receptor (CAR) T cell therapy is changing the paradigm in hematologic malignancies, but disparities in access exist in the real-world setting. Efforts to address and eliminate these disparities...